CMKLR1 and idiopathic pulmonary fibrosis: Together, these findings support that the heterogeneous CMKLR1 expression may be harnessed to identify a distinct endotype of IPF with a more intense inflammatory and ECM remodeling profile associated with a high risk of progression and mortality over a short-to-intermediate interval.